TriSalus Life Sciences's total assets for Q1 2025 were $28.63M, an increase of 19.42% from the previous quarter. TLSI total liabilities were $62.99M for the fiscal quarter, a 26.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.